| US 7,595,045 B2 | ||
| Anti-α9 integrin antibody and the use thereof | ||
| Daisuke Kurotaki, Sapporo (Japan); Masashi Kanayama, Sapporo (Japan); Shigeyuki Kon, Sapporo (Japan); and Toshimitsu Uede, Sapporo (Japan) | ||
| Assigned to Gene Techno Science Co., Ltd., Hokkaido (Japan) | ||
| Appl. No. 11/795,045 PCT Filed Jan. 12, 2006, PCT No. PCT/JP2006/300676 § 371(c)(1), (2), (4) Date Jul. 11, 2007, PCT Pub. No. WO2006/075784, PCT Pub. Date Jul. 20, 2006. |
||
| Claims priority of application No. 2005-006348 (JP), filed on Jan. 13, 2005. | ||
| Prior Publication US 2008/0152653 A1, Jun. 26, 2008 | ||
| Int. Cl. A61K 39/395 (2006.01); C07K 16/28 (2006.01) | ||
| U.S. Cl. 424—130.1 [424/143.1; 424/144.1; 530/388.22] | 6 Claims |
| 1. A monoclonal antibody, which is produced by a hybridoma designated by Accession No. FERM BP-10195, FERM BP-10196, FERM BP-10197 or FERM BP-10198. |